Korea

STRADVISION Renews ISO 27001 Certification, Solidifying Leadership in Automotive Technology Security

SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- STRADVISION , a trailblazer in the automotive technology sector, proudly announces the successful renewal of its ISO 27001 certification for the fourth consecutive year. This achievement reaffirms STRADVISION...

2024-03-11 23:00 1813

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...

2024-03-11 20:00 1437

Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.

SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Wellysis, a digital healthcare company spun off from Samsung, has announced the launch of remote cardiac monitoring service in the US in partnership with Artella Solutions (ARTELLA). Sepand...

2024-03-08 22:00 3211

Game Backend SaaS BACKND to Showcase at 'GDC 2024', Introduces Enhanced Chat Service

- Game Backend SaaS BACKND to Showcase at 'GDC 2024' with Dedicated Booth - BACKND Server Introduces Upgraded Chat Service to the Global Market SEOUL, South Korea, March 7, 2024 /PRNewswire/ -- AFI, the operator of BACKND, a game backend SaaS platform, announced its participation with a dedicate...

2024-03-07 21:00 1526

EDINT wins iF Award 2024 for Proctormatic, a mobile-based AI proctoring service

DAEJEON, South Korea, March 6, 2024 /PRNewswire/ -- EDINT, an AI EdTech startup, announced onMarch 5th that its mobile-based AI online exam proctoring service, Proctormatic, has won the world-renowned International Forum (iF) Design Award 2024.

2024-03-06 15:25 2104

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

- Showcases brain imaging analysis technology with key products Neurophet AQUA and Neurophet SCALE PET - Aims to commercialize ARIA analysis and amyloid-positive prediction technology SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company f...

2024-03-04 22:00 1577

KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide

* Evaluated firstly as a L'Oreal partner in 2013 and achieved the highest rating in 11 years * Efforts to establish an ESG committee, reinforce labor and human rights management, and improve management of partners SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Samyang Group announced that ...

2024-03-04 21:30 1489

LG OLED AND SHEPARD FAIREY TAKE STREET ART INTO THE DIGITAL REALM

American Street Artist and Social Activist, Shepard Fairey Chooses LG OLED as His Digital Canvas at Frieze LA SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- At Frieze Los Angeles 2024, LG OLED is joining forces with Shepard Fairey, the acclaimed contemporary street artist, social activist and...

2024-03-01 02:00 2113

SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer

SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onFeb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development, based on the pre-clinical dat...

2024-02-29 18:09 1619

Gauss Labs and SK hynix Publish the Latest Results on AI-based Semiconductor Metrology Technology at SPIE AL 2024

-  Two joint academic papers on AI-based metrology technology presented -  Gauss Labs's innovative technology improves process control and equipment productivity in semiconductor manufacturing -  Gauss Labs is at the forefront, leading industrial AI efforts to transform the manufacturing industr...

2024-02-29 13:50 1556

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammography double-reading settings  SEOUL, South Korea, Feb. 28...

2024-02-28 22:03 1388

STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology

SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- Building on the success of its groundbreaking SVNet with 3D Perception Technology,STRADVISION , a trailblazer in the automotive technology sector, proudly announces yet another milestone achievement, surpassin...

2024-02-27 00:00 1406

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

* Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use inSouth Korea as an adjuvant cell therapy for the treatment of Hepatocellular Carcinoma (HCC) after curative resection and has receivedFDA Orphan Drug Designations (ODDs) for liver, brain...

2024-02-26 21:30 1414

SAPEON collaborates with DOCOMO Innovations for AI services enhancement

SAPEON collaborates with DOCOMO Innovations to conduct a PoC (Proof of Concept) for providing AI services SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- SAPEON (CEO Soojung Ryu, www.sapeon.com ), a global AI semiconductor company, proudly announced their partnership wi...

2024-02-26 21:00 1137

J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)

SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- J INTS BIO announced on the 26th of month that the Phase 1/2 clinical study of its Novel Oral 4th Generation EGFR TKI "JIN-A02" for the treatment of NSCLC has been accepted for poster presentation at the upcoming American Association for Cancer Re...

2024-02-26 16:15 1210

Flow Studio Takes Another Step Forward with CES 2024 Win

POHANG-SI, South Korea, Feb. 23, 2024 /PRNewswire/ -- Flow Studio a prominent South Korean EduTech startup, secured global acclaim by winning the coveted Best Innovation Award at CES 2024. Among the 4,000 participating companies, Flow Studio emerged as o...

2024-02-23 22:00 2401

Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease

PANGYO, South Korea, Feb. 23, 2024 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing a novel disease-modifying immunothera...

2024-02-23 21:00 1962

AUTOCRYPT Launches Cybersecurity Testing Platform for UN R155/156 and GB Compliance

New platform enables automotive OEMs to conduct regulatory compliant security testing and share integrated results for vehicle type approval SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- Automotive cybersecurity company AUTOCRYPT announced the launch of AutoCrypt CSTP, a comprehensive cybers...

2024-02-20 22:00 1668

Integrit Unveils 'Stella': Pioneering AI Hardware Generating Dynamic Interactions with LLMs

SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- AI Robotics platform specialist Integrit (Seoul/integrit.ai ) announced on the 1st that it is commercializing a groundbreaking generative AI hardware device called 'Stella' (pictured). Stella automatically generate...

2024-02-20 21:00 1883

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

 - A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint Inhibitor across multiple cancer types SEOUL, South Korea, Feb. ...

2024-02-16 22:03 5195
1 ... 18192021222324 ... 110